Kaosheng Lv

672 total citations
18 papers, 409 citations indexed

About

Kaosheng Lv is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Kaosheng Lv has authored 18 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Hematology and 3 papers in Genetics. Recurrent topics in Kaosheng Lv's work include Acute Myeloid Leukemia Research (6 papers), Ubiquitin and proteasome pathways (6 papers) and RNA modifications and cancer (5 papers). Kaosheng Lv is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Ubiquitin and proteasome pathways (6 papers) and RNA modifications and cancer (5 papers). Kaosheng Lv collaborates with scholars based in China, United States and Thailand. Kaosheng Lv's co-authors include Wei Tong, Jian‐Gang Ren, Jun Gui, Guangping Liu, Ying Cheng, Chunlin Wu, Wenlin Wu, Jianping Xiong, Junlin Teng and Stephen C. Meredith and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Kaosheng Lv

16 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaosheng Lv China 12 295 89 84 61 54 18 409
Wendy Fang United States 9 383 1.3× 100 1.1× 124 1.5× 165 2.7× 91 1.7× 17 563
Megha Rajaram India 6 205 0.7× 72 0.8× 61 0.7× 70 1.1× 43 0.8× 6 331
Samantha Messina Italy 10 344 1.2× 60 0.7× 23 0.3× 52 0.9× 43 0.8× 23 442
Somsundar Veppil Muralidharan Sweden 9 451 1.5× 134 1.5× 85 1.0× 106 1.7× 30 0.6× 12 525
Ilaria Marzi Italy 13 159 0.5× 52 0.6× 47 0.6× 63 1.0× 16 0.3× 18 350
Kasyapa S. Chitta United States 12 275 0.9× 119 1.3× 71 0.8× 35 0.6× 53 1.0× 29 483
Janani Kumar Australia 9 215 0.7× 204 2.3× 30 0.4× 109 1.8× 65 1.2× 10 433
Nimesh Bhaskaran Sweden 6 223 0.8× 57 0.6× 141 1.7× 42 0.7× 39 0.7× 8 449
Sanket S. Acharya United States 5 441 1.5× 95 1.1× 49 0.6× 194 3.2× 52 1.0× 8 531
Brooke A. Conti United States 8 416 1.4× 115 1.3× 28 0.3× 74 1.2× 49 0.9× 12 518

Countries citing papers authored by Kaosheng Lv

Since Specialization
Citations

This map shows the geographic impact of Kaosheng Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaosheng Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaosheng Lv more than expected).

Fields of papers citing papers by Kaosheng Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaosheng Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaosheng Lv. The network helps show where Kaosheng Lv may publish in the future.

Co-authorship network of co-authors of Kaosheng Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Kaosheng Lv. A scholar is included among the top collaborators of Kaosheng Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaosheng Lv. Kaosheng Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Lei, Xuezhen Ma, Yaohui He, et al.. (2025). Rbm38 deficiency impairs erythroid heme biosynthesis and induces porphyria via reduced ferrochelatase expression. Blood. 146(25). 3106–3123.
2.
Chen, Yafei, Xinying Wang, Yudan Gao, et al.. (2024). LNK/SH2B3 Loss Exacerbates the Development of Myeloproliferative Neoplasms in CBL-deficient Mice. Stem Cell Reviews and Reports. 21(2). 509–519.
3.
Ma, Junkai, Xuan Ju, Siying Chen, et al.. (2024). Vasopressin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in mice. Cell stem cell. 31(12). 1794–1812.e10. 6 indexed citations
4.
Ren, Jian‐Gang, Bowen Xing, Kaosheng Lv, et al.. (2023). RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. Journal of Clinical Investigation. 133(12). 24 indexed citations
5.
Dong, Yuechao, Guixing Ma, Yingying Han, et al.. (2023). Kindlin-2 controls angiogenesis through modulating Notch1 signaling. Cellular and Molecular Life Sciences. 80(8). 223–223. 6 indexed citations
6.
Thorsheim, Chelsea, Yuxi Ai, Long Gao, et al.. (2022). Control of ribosomal RNA synthesis by hematopoietic transcription factors. Molecular Cell. 82(20). 3826–3839.e9. 11 indexed citations
7.
Ma, Junkai, Rui Jiang, Siying Chen, et al.. (2022). Meteorin links the bone marrow hypoxic state to hematopoietic stem/progenitor cell mobilization. Cell Reports. 40(12). 111361–111361. 10 indexed citations
8.
Lv, Kaosheng & Wei Tong. (2022). A protein synthesis brake for hematopoietic stem cell maintenance. Genes & Development. 36(15-16). 871–873. 1 indexed citations
9.
Lv, Kaosheng, et al.. (2021). Depalmitoylation rewires FLT3-ITD signaling and exacerbates leukemia progression. Blood. 138(22). 2244–2255. 43 indexed citations
10.
Lv, Kaosheng, Jian‐Gang Ren, Ying Cheng, et al.. (2021). HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis. Cell stem cell. 28(7). 1275–1290.e9. 42 indexed citations
11.
Lv, Kaosheng, et al.. (2019). The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination. Blood. 133(14). 1560–1571. 24 indexed citations
12.
Balcerek, Joanna, Jing Jiang, Yang Li, et al.. (2018). Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia. Nature Communications. 9(1). 3915–3915. 16 indexed citations
13.
Lv, Kaosheng, Jing Jiang, Ying Cheng, et al.. (2017). CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies. Genes & Development. 31(10). 1007–1023. 46 indexed citations
14.
Hao, Qiongyu, Jianyuan Luo, Jianping Xiong, et al.. (2015). USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2. Oncogene. 35(22). 2902–2912. 67 indexed citations
15.
Lv, Kaosheng, Liang Chen, Yuanjun Li, et al.. (2015). Trip6 Promotes Dendritic Morphogenesis through Dephosphorylated GRIP1-Dependent Myosin VI and F-Actin Organization. Journal of Neuroscience. 35(6). 2559–2571. 12 indexed citations
16.
Wu, Wenlin, et al.. (2014). USP11 regulates p53 stability by deubiquitinating p53. Journal of Zhejiang University SCIENCE B. 15(12). 1032–1038. 51 indexed citations
17.
18.
Liu, Yingying, et al.. (2012). PACSIN1, a Tau-interacting Protein, Regulates Axonal Elongation and Branching by Facilitating Microtubule Instability. Journal of Biological Chemistry. 287(47). 39911–39924. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026